首页 › 基金 › STRATEGIC PLANNING GROUP, LLC › VRTX
STRATEGIC PLANNING GROUP, LLC 对 VRTX 的持仓历史
VERTEX PHARMACEUTICALS INC · 医疗保健
STRATEGIC PLANNING GROUP, LLC 在 Q3 2026 的 13F 申报中披露持有 VRTX(VERTEX PHARMACEUTICALS INC)19,483 股,市值约 US$10.2M,约占其申报组合的 1.06%,在其申报持仓中市值排名第 38 位。 STRATEGIC PLANNING GROUP, LLC 最近 12 个申报季度中有 5 个季度披露了 VRTX 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-22 · 来源: SEC EDGAR Form 13F-HR
STRATEGIC PLANNING GROUP, LLC 对 VRTX 的持仓演变
STRATEGIC PLANNING GROUP, LLC 于 Q4 2023 首次披露 VRTX 持仓:2,932 股(约 US$1.2M)。 该持仓在 Q3 2026 达到峰值 19,483 股,市值约 US$10.2M。 在 5 次申报中,STRATEGIC PLANNING GROUP, LLC 3 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 19,483 股、市值约 US$10.2M,环比增持 817 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 2.93K | $1.19M | 新进 |
| Q1 2024 | 3.07K | $1.28M | 增持 |
| Q1 2026 | 17.39K | $7.77M | 新进 |
| Q2 2026 | 18.67K | $9.27M | 增持 |
| Q3 2026 | 19.48K | $10.19M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 VRTX 与 13F 数据
VRTX(VERTEX PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 VRTX,申报仓位最大的包括:资本世界投资者 (US$12.97B), Capital World Investors (US$12.97B), 资本研究全球投资者 (US$9.68B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VRTX 的基金
- 资本世界投资者 26.12M 股 · $12.97B · Q2 2026
- Capital World Investors 26.12M 股 · $12.97B · Q2 2026
- 资本研究全球投资者 19.49M 股 · $9.68B · Q2 2026
- Capital Research Global Investors 19.49M 股 · $9.68B · Q2 2026
- 景顺 8.04M 股 · $4.00B · Q2 2026
- LOOMIS SAYLES & CO L P 3.92M 股 · $1.95B · Q2 2026
- JENNISON ASSOCIATES LLC 3.00M 股 · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M 股 · $1.35B · Q2 2026
- Clearbridge Investments, LLC 2.34M 股 · $1.16B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.17M 股 · $1.08B · Q2 2026
- 骏利亨德森集团 2.13M 股 · $951.79M · Q1 2026
更多关于 STRATEGIC PLANNING GROUP, LLC
常见问题
How long has STRATEGIC PLANNING GROUP, LLC held VRTX?
STRATEGIC PLANNING GROUP, LLC has disclosed VRTX holdings in 5 of the last 12 reported quarters, going back to Q4 2023.
What is STRATEGIC PLANNING GROUP, LLC's current position in VRTX?
As of Q3 2026, STRATEGIC PLANNING GROUP, LLC holds 19.48K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $10.19M, representing 1.06% of its reported portfolio and ranking #38.
Has STRATEGIC PLANNING GROUP, LLC been buying or selling VRTX?
In the latest 13F filing (Q3 2026), STRATEGIC PLANNING GROUP, LLC increased its position in VRTX. The position peaked in Q3 2026 at 19.48K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include 资本世界投资者, Capital World Investors, 资本研究全球投资者, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.